INTRAHEPATIC EXPRESSION OF PD-1, PD-L1 AND PD-L2 IN CHRONIC HEPATITIS B PATIENTS

被引：0
|
作者：
Chen, J. [1 ]
Lan, M. -D. [2 ]
Wu, X. -J. [1 ]
Zhao, J. -M. [3 ]
Lan, Z. -W. [2 ]
Wang, G-Q [1 ]
机构：
[1] Peking Univ, Hosp 1, Beijing 100871, Peoples R China
[2] Peking Di Tan Hosp, Beijing, Peoples R China
[3] 302 Hosp, Beijing, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 50卷
关键词：
D O I：
10.1016/S0168-8278(09)60558-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
556
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 50 条
  • [21] PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation
    del Rio, Maria-Luisa
    Buhler, Leo
    Gibbons, Carrie
    Tian, Jiong
    Rodriguez-Barbosa, Jose-Ignacio
    TRANSPLANT INTERNATIONAL, 2008, 21 (11) : 1015 - 1028
  • [22] Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues
    Ishida, M
    Iwai, Y
    Tanaka, Y
    Okazaki, T
    Freeman, GJ
    Minato, N
    Honjo, T
    IMMUNOLOGY LETTERS, 2002, 84 (01) : 57 - 62
  • [23] Expression of Immunomodulatory Molecules PD-1, PD-L1, and PD-L2, and their Relationship With Clinicopathologic Characteristics in Endometrial Cancer
    Sungu, Nuran
    Yildirim, Melahat
    Desdicioglu, Raziye
    Aydogdu, Ozge Basaran
    Kilicarslan, Aydan
    Dogan, Hayriye Tatli
    Yazgan, Aylin Kilic
    Akyol, Mesut
    Erdogan, Fazli
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2019, 38 (05) : 404 - 413
  • [24] Expression of PD-1, PD-L1 and PD-L2 is associated with differentiation status and histological type of endometrial cancer
    Mo, Zhongfu
    Liu, Jing
    Zhang, Qiuyang
    Chen, Zhiquan
    Mei, Jiandong
    Liu, Lunxu
    Yang, Shijie
    Li, Huina
    Zhou, Lifei
    You, Zongbing
    ONCOLOGY LETTERS, 2016, 12 (02) : 944 - 950
  • [25] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment (vol 121, pg 251, 2015)
    Mathios, Dimitrios
    Ruzevick, Jacob
    Jackson, Christopher M.
    Xu, Haiying
    Shah, Sagar R.
    Taube, Janis M.
    Burger, Peter C.
    McCarthy, Edward F.
    Quinones-Hinojosa, Alfredo
    Pardoll, Drew M.
    Lim, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2016, 128 (01) : 183 - 183
  • [26] Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation
    Kinch, Amelie
    Sundstrom, Christer
    Baecklund, Eva
    Backlin, Carin
    Molin, Daniel
    Enblad, Gunilla
    LEUKEMIA & LYMPHOMA, 2019, 60 (02) : 376 - 384
  • [27] Association of PD-1, PD-L1 and PD-L2 expression with clinicopathological factors in tongue squamous cell carcinoma
    Tsuchihashi, Kei
    Nakatsugawa, Munehide
    Asanuma, Hiroko
    Miyazaki, Akihiro
    Torigoe, Toshihiko
    CANCER SCIENCE, 2018, 109 : 498 - 498
  • [28] Serum Level of PD-1, PD-L1, and PD-L2 as a New Biomarker for Esophageal Cancer
    Akutsu, Yasunori
    Murakami, Kentaro
    Hanari, Naoyuki
    Kano, Masayuki
    Uesato, Masaya
    Ota, Takumi
    Suito, Hiroshi
    Matsumoto, Yasunori
    Takahashi, Masahiko
    Matsubara, Hisahiro
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S694 - S694
  • [29] Possibility of PD-1/PD-L1 inhibitors for the treatment of patients with chronic hepatitis B infection
    Su, Menghan
    Ye, Ting
    Wu, Wei
    Shu, Zheyue
    Xia, Qi
    DIGESTIVE DISEASES, 2024, 42 (01) : 53 - 60
  • [30] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
12345